← Live StudiesRegistry: recruitingPhase 3

ENLIGHTEN-2: Eloralintide for obesity with type 2 diabetes

Compares once-weekly investigational eloralintide with placebo for body weight reduction in adults with overweight or obesity and type 2 diabetes.

Ask about this study Refer a patient View official study record

Who it's for

Age 18+
Type 2 diabetes
BMI ≥27
Stable diabetes treatment

Full eligibility rules apply. The study team decides who can take part.

Where it runs

13 research locations in Arizona, California, Hawaii and Utah.

Arizona

Tucson Clinical Research InstituteTucson, AZ

California

San Fernando Valley Health InstituteCanoga Park, CA
AMCR InstituteEscondido, CA
NorCal Medical Research, IncGreenbrae, CA
Ark Clinical ResearchLong Beach, CA
Pacific Clinical StudiesLos Alamitos, CA
Inglewood ClinicalLos Angeles, CA
Care Access - Santa ClaritaSanta Clarita, CA
Encompass Clinical ResearchSpring Valley, CA
Diablo Clinical Research, Inc.Walnut Creek, CA

Hawaii

Pacific Diabetes & Endocrine CenterHonolulu, HI

Utah

Ogden Clinic - Canyon ViewOgden, UT
Diabetes & Endocrine Treatment SpecialistsSandy City, UT

Site recruitment may change. The official record lists every location, including outside these states.

Interested in this study?

Ask us about it, or refer a patient. Taking part is voluntary, and the study team decides who can join.

Ask about this study Refer a patient

Important information about clinical research

InvestigatorX is an independent information directory. Being listed here does not mean a sponsor, research institution or investigator is affiliated with InvestigatorX. ClinicalTrials.gov registration is not FDA approval of a study drug, an endorsement, or confirmation that a particular site is currently accepting participants.

Summaries are informational and do not determine clinical eligibility. Research can involve risks, including investigational medications and placebo assignment. Always review the ClinicalTrials.gov study basics and speak with a qualified healthcare professional and the authorized study team.

No medical information is collected on this page. For accurate criteria, contacts, and the latest recruitment status, select View official study record on each study's page.

Research listings compiled October 20, 2026. Source: U.S. ClinicalTrials.gov and registry-indexed study information. Independent site; not a U.S. government service. Study data can change without notice.